The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.20 (16.667%)
Open: 1.30
High: 1.30
Low: 1.30
Prev. Close: 1.30
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: G4S And Tullow Oil Lead FTSE 100 Gainers

Wed, 12th Nov 2014 12:02

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
G4S, up 4.3%. The security company said organic revenue rose 4.2% in the first nine months of the year and it has agreed new contracts with annual revenues of over GBP870 million and total contract value of GBP1.7 billion. Contract retention for the nine months was similar to historical levels, at slightly above 90%, the company said.

Tullow Oil, up 1.5%. The oil explorer said it is reviewing its capital expenditure and costs, with overall exploration spending significantly reduced and focused primarily on East Africa where it has major basin-opening potential.
-------
FTSE 100 LOSERS
-------
Sainsbury's, down 5.4%. The supermarket operator swung to a pretax loss in the first half of the year, and outlined plans to cuts costs and capital expenditure. Pretax loss was GBP290 million for the 28 weeks to September 27 from a profit of GBP433 million in the same period a year earlier. First-half revenue fell 0.1% to GBP12.67 billion. It maintained its interim dividend, but its full-year dividend is expected to be cut.

Capita, down 5%. The outsourcing company said it has secured GBP1.63 billion of major sales so far this year, down from GBP2.9 billion in the same period last year when it had booked its largest ever contract worth GBP1.2 billion with O2.

SSE, down 2.7%. The utility reported a drop in pretax profit in the first half of the year due to warmer weather, lower electricity output and weak gas prices. For the six months ended September 30, pretax profit fell 6.2% to GBP316.6 million compared with GBP337.4 million a year earlier, mainly driven by a GBP22.1 million loss from its share of joint ventures.

Barclays, down 2%. The bank was among the five investigated by regulators over its FX dealings but remains in talks with regulators over its settlement. It has set aside GBP500 million in provisions to cover potential fines.

Burberry, down 1.2%. The luxury fashion retailer reported a 14% rise in underlying revenue of GBP1.1 billion but said it expects some pressure on full-year margin, a reflection of the strong pound, a more difficult external environment, and continued investments.

Royal Bank of Scotland, down 0.4%. The bank was one of five fined a total USD3.38 billion by UK, US and Swiss regulators for failings in its FX dealing operations. RBS was fined GBP399 million but said this is fully covered by provisions made in the third quarter.
-------
FTSE 250 WINNERS
-------
Essentra, up 2.5%. The company said it will buy the specialist packing arm of Clondalkin Group in a USD455 million deal, issuing shares to cover GBP160 million of the consideration. Clondalkin, which provides secondary packaging products for the pharmaceutical and healthcare industries, is owned by an affiliate of US private equity house Warburg Pincus and Essentra expects to complete the deal in the first quarter of 2015.

Moneysupermarket.com, up 2%. The price comparison website said it remains confident of meeting its expectations for the full year, after the "positive momentum and solid margins" seen in the third quarter continued through October. Third-quarter revenue rose by 18% year-on-year to GBP66.8 million, driven by increases in MoneySuperMarket.com, MoneySavingExpert.com, and TravelSupermarket.com, the company said
-------
FTSE 250 LOSERS
-------
SIG, down 7.5%. The building products distributor lowered its expectations for the year due to weak economic conditions in Europe, although it also raised its cost-benefit targets from the strategic initiatives it is taking.

Playtech, down 7.5%. Credit Suisse cut its rating on the stock to Underperform from Neutral and lowered its price target to 580 pence from 780p.

Diploma, down 1.6%. The company said Chairman John Rennocks is to step down from his role after the company's annual general meeting in January, appointing John Nicholas, currently a senior independent director on Diploma's board.
-------
AIM ALL-SHARE WINNERS
-------
Mountfield, up 8.1%. The company said its Connaught Access Flooring subsidiary has won a contract worth around GBP4.5 million to supply and install access flooring at a newly-built office development in the City of London. Work will start in January 2015 and is expected to be completed in the first quarter of 2016.

Solo Oil, up 7%. The company said it is awaiting formal approval from Tanzanian authorities for a deal that will see Solo buy a stake in the Kiliwani North Development license from Aminex, and the companies expect the deal to close shortly.
-------
AIM ALL-SHARE LOSERS
-------
Proteome Sciences, down 16%. The company said contract delays will mean its full-year revenue will come in below market expectations and lower than the revenue posted last year.

Quindell, down 9.6%. The company is understood to be on the brink of a formal probe by the City regulator over a share-transaction controversy which has caused its share price to plunge in the past week, the Daily Mail reported. The FCA declined to comment to Alliance News.

Physiomics, down 4%. The company posted a slightly narrowed loss in its year to end-June of GBP464,252, down from GBP543,791 a year before, as revenue rose to GBP267,903 from GBP240,000.
-------
By Ian Edmondson; ianedmondson@alliancenews.com;

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
14 May 2021 10:23

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

Read more
14 May 2021 09:27

Physiomics secures follow-on contract from Merck KgaA

Physiomics secures follow-on contract from Merck KgaA

Read more
14 May 2021 08:27

Physiomics secures additional contract with Merck

(Sharecast News) - Drug development consultancy Physiomics has been awarded a further contract with a leading science and technology company Merck.

Read more
11 May 2021 17:50

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

Read more
11 May 2021 10:46

Physiomics secures contract with Numab Therapeutics

(Sharecast News) - Consultancy firm Physiomics said on Tuesday that it has been awarded a first contract with new client Numab Therapeutics.

Read more
10 May 2021 10:21

Physiomics says full-year results to disappoint market forecasts

Physiomics says full-year results to disappoint market forecasts

Read more
10 May 2021 10:19

AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake

AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake

Read more
10 May 2021 08:40

Physiomics FY income likely to fall short of market expectations

(Sharecast News) - Technology-based solutions provider Physiomics said on Monday that total income for the financial year ending 30 June was likely to be below market expectations due to both Covid-19 related project delays and an increased focus on longer-term value-generating activities.

Read more
1 Mar 2021 11:29

AIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes

AIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes

Read more
1 Mar 2021 11:22

TRADING UPDATES: CentralNic revenue doubles; Augean swing to profit

TRADING UPDATES: CentralNic revenue doubles; Augean swing to profit

Read more
15 Feb 2021 16:04

Physiomics and ValiRx enter new collaboration deal

(Sharecast News) - Oncology consulting company Physiomics has entered into a new agreement with clinical-stage drug development company ValiRx, it announced on Monday, superseding the agreement between the two companies, which was announced in September 2011.

Read more
15 Feb 2021 11:05

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

Read more
17 Dec 2020 15:52

UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand

UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand

Read more
17 Dec 2020 13:59

Physiomics gets initial 2021 commitment from client Merck

(Sharecast News) - Oncology consultancy Physiomics announced on Thursday that its existing client, Merck, has committed to an initial tranche of projects for 2021 with a total value of £0.27m.

Read more
14 Dec 2020 19:35

UK TRADING UPDATE SUMMARY: Airtel Investor To Sell 60 Million Shares

UK TRADING UPDATE SUMMARY: Airtel Investor To Sell 60 Million Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.